Proapoptotic bid is required for pulmonary fibrosis

被引:91
作者
Budinger, GRS
Mutlu, GM
Eisenbart, J
Fuller, AC
Bellmeyer, AA
Baker, CM
Wilson, M
Ridge, K
Barrett, TA
Lee, VY
Chandel, NS [1 ]
机构
[1] Northwestern Univ, Dept Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Immunol Microbiol, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA
关键词
apoptosis; Bcl-2; TGF-beta;
D O I
10.1073/pnas.0507604103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The molecular mechanisms of pulmonary fibrosis are poorly understood. Previous reports indicate that activation of TGF-beta 1 is essential for the development of pulmonary fibrosis. Here, we report that the proapoptotic Bcl-2 family member Bid is required for the development of pulmonary fibrosis after the intratracheal instillation of bleomycin. Mice lacking Bid exhibited significantly less pulmonary fibrosis in response to bleomycin compared with WT mice. The attenuation in pulmonary fibrosis was observed despite similar levels of inflammation, lung injury, and active TGF-beta 1 in bronchoalveolar lavage fluid 5 days after the administration of bleomycin in mice lacking Bid and in WT controls. Bleomycin induced similar levels cell death in vitro in alveolar epithelial cells isolated from WT and bid(-/-) mice. By contrast, alveolar epithelial cells from bid(-/-) mice were resistant to TGF-beta 1-induced cell death. These results indicate that Bcl-2 family members are critical regulators for the development of pulmonary fibrosis downstream of TGF-beta 1 activation.
引用
收藏
页码:4604 / 4609
页数:6
相关论文
共 35 条
[1]  
ADAMSON IYR, 1988, AM J PATHOL, V130, P377
[2]   The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice [J].
Aoshiba, K ;
Yasui, S ;
Tamaoki, J ;
Nagai, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :695-700
[3]   Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor [J].
Bonniaud, P ;
Margetts, PJ ;
Kolb, M ;
Schroeder, JA ;
Kapoun, AM ;
Damm, D ;
Murphy, A ;
Chakravarty, S ;
Dugar, S ;
Higgins, L ;
Protter, AA ;
Gauldie, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) :889-898
[4]   Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis [J].
Bonniaud, P ;
Kolb, M ;
Galt, T ;
Robertson, J ;
Robbins, C ;
Stampfli, M ;
Lavery, C ;
Margetts, PJ ;
Roberts, AB ;
Gauldie, J .
JOURNAL OF IMMUNOLOGY, 2004, 173 (03) :2099-2108
[5]   Active transforming growth factor-β1 activates the procollagen I promoter in patients with acute lung injury [J].
Budinger, GRS ;
Chandel, NS ;
Donnelly, HK ;
Eisenbart, J ;
Oberoi, M ;
Jain, M .
INTENSIVE CARE MEDICINE, 2005, 31 (01) :121-128
[6]   Pulmonary fibrosis - Searching for model answers [J].
Chua, F ;
Gauldie, J ;
Laurent, GJ .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 33 (01) :9-13
[7]   Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219
[8]  
Gauldie J, 2001, RESP RES, V3
[9]   EFFECT OF ANTIBODY TO TRANSFORMING GROWTH-FACTOR-BETA ON BLEOMYCIN-INDUCED ACCUMULATION OF LUNG COLLAGEN IN MICE [J].
GIRI, SN ;
HYDE, DM ;
HOLLINGER, MA .
THORAX, 1993, 48 (10) :959-966
[10]   The pathophysiology of mitochondrial cell death [J].
Green, DR ;
Kroemer, G .
SCIENCE, 2004, 305 (5684) :626-629